1-6 of 6
M King
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Outcomes of Primary Bone Diffuse Large B-Cell Lymphoma in the Rituximab Era: A Multicenter Retrospective Analysis

Alexandra Rezazadeh, Aniko Szabo, Kathleen Monahan, Arushi Khurana, David J. Inwards, Matthew A. Lunning, Amanda Cashen, Nancy L. Bartlett, Paolo F. Caimi, Thomas D. Rodgers, Paul M. Barr, Sayan Mullick Chowdhury, Narendranath Epperla, Hiruni Mendries, Brian T. Hill, Timothy Seijung Oh, Reem Karmali, Julie E. Chang, Gaurav Goyal, Benjamin M Parsons, Krista M. Isaac, Craig A. Portell, Malika Siker, David M King, Timothy S. Fenske
Journal: Blood
Blood (2021) 138 (Supplement 1): 1451.
https://doi.org/10.1182/blood-2021-145145
Published: 2021
Journal Articles

A Phase Ia/Ib Study Exploring the Synthetic Lethality of the Orally Administered Novel BTK Inhibitor, Dtrmwxhs-12 (DTRM-12), in Combination with Everolimus and Pomalidomide in Patients with Relapsed/Refractory CLL, DLBCL or Other B-Cell Lymphomas

Anthony R. Mato, MDMSCE, Stephen J Schuster, MD, Francine M. Foss, MD, Iris Isufi, MD, Wei Ding, MD PhD, Danielle M. Brander, MD, Andrea Sitlinger, MD, Han W. Tun, MD, Muhamad Alhaj Moustafa, MD, Kaitlin Kennard, RN, BSN, Cara M King, MPH, Amber Koehler, PA-C, MS, Casey Aitken, Wei He, PhD, Albert Kearney, PhD, Min Gui, PhD, Barry Douglas Anderson, MD PhD, Allison C. Rosenthal, DO, Lindsey E. Roeker, MD, Scott F. Huntington, MD MPH
Journal: Blood
Blood (2019) 134 (Supplement_1): 810.
https://doi.org/10.1182/blood-2019-126192
Published: 2019
Journal Articles

Phase I/II Study of Umbralisib (TGR-1202) in Combination with Ublituximab (TG-1101) and Pembrolizumab in Patients with Relapsed/Refractory CLL and Richter's Transformation

Anthony R. Mato, MDMSCE, Jakub Svoboda, MD, Eline T. Luning Prak, MD,PhD, Stephen J. Schuster, MD, Patricia Tsao, MD PhD, Colleen Dorsey, BSN, RN, Pamela S. Becker, MD, Danielle M. Brander, MD, Sunita Dwivedy Nasta, MD, Daniel J. Landsburg, MD, Cara M King, MPH, Beth Morrigan, Kaitlin Kennard, RN, BSN, Lindsey E. Roeker, MD, Andrew D. Zelenetz, MD PhD, Michelle Purdom, PhDRN, Dana Paskalis, Peter Sportelli, BS, Hari P Miskin, MSc, Michael S. Weiss, Mazyar Shadman, MD MPH
Journal: Blood
Blood (2018) 132 (Supplement 1): 297.
https://doi.org/10.1182/blood-2018-99-117526
Published: 2018
Journal Articles

CD28-mediated regulation of multiple myeloma cell proliferation and survival

Nizar J. Bahlis, Anne M. King, Despina Kolonias, Louise M. Carlson, Hong Yu Liu, Mohamad A. Hussein, Howard R. Terebelo, Gerald E. Byrne, Jr, Bruce L. Levine, Lawrence H. Boise, Kelvin P. Lee
Journal: Blood
Blood (2007) 109 (11): 5002–5010.
https://doi.org/10.1182/blood-2006-03-012542
Published: 2007
Journal Articles

CD28-Mediated Regulation of Multiple Myeloma Cell Proliferation and Survival.

Kelvin P. Lee, MD, Nizar J. Bahlis, MD, Anne M. King, MS, Despina Kolonias, BS, Louise M. Carlson, BS, Mohamad Hussein, MD, Howard Terebolo, DO, Gerald E. Byrne, Jr., MD, Bruce L. Levine, Ph.D, Lawrence H. Boise, Ph.D
Journal: Blood
Blood (2005) 106 (11): 355.
https://doi.org/10.1182/blood.V106.11.355.355
Published: 2005
Journal Articles

Monocyte Fc gamma receptor recognition of cell-bound and aggregated IgG

F Gomez, P Chien, M King, P McDermott, AI Levinson, MD Rossman, AD Schreiber
Journal: Blood
Blood (1989) 74 (3): 1058–1065.
https://doi.org/10.1182/blood.V74.3.1058.1058
Published: 1989